scholarly journals Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

2021 ◽  
Author(s):  
Anca D. Askanase ◽  
Enxu Zhao ◽  
Julie Zhu ◽  
Roman Bilyk ◽  
Richard A. Furie
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Controlled Trial ◽  
Active Systemic Lupus Erythematosus ◽  
Systemic Lupus ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

2009 ◽  
Vol 61 (9) ◽  
pp. 1168-1178 ◽  
Author(s):  
Daniel J. Wallace ◽  
William Stohl ◽  
Richard A. Furie ◽  
Jeffrey R. Lisse ◽  
James D. McKay ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Phase Ii ◽  
Lupus Erythematosus ◽  
Active Systemic Lupus Erythematosus ◽  
Systemic Lupus ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Ranging

scholarly journals Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: A randomized, double-blind, placebo-controlled trial

2002 ◽  
Vol 46 (12) ◽  
pp. 3251-3258 ◽  
Author(s):  
Kenneth C. Kalunian ◽  
John C. Davis ◽  
Joan T. Merrill ◽  
Mark C. Totoritis ◽  
David Wofsy ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
T Cell ◽  
Lupus Erythematosus ◽  
Controlled Trial ◽  
Systemic Lupus ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document